Medical Care
Global Targeted-protein Degradation Therapeutics Market Insights, Forecast to 2030
- Mar 11, 25
- ID: 4314
- Pages: 72
- Figures: 101
- Views: 1
Targeted protein degradation (TPD) has surfaced as a novel and innovative chemical tool and therapeutic modality. By co-opting protein degradation pathways, TPD facilitates complete removal of the protein molecules from within or outside the cell. While the pioneering Proteolysis-Targeting Chimera (PROTAC) technology and molecular glues hijack the ubiquitin-proteasome system, newer modalities co-opt autophagy or the endo-lysosomal pathway.
Market Analysis and Insights: Global Targeted-protein Degradation Therapeutics Market
The global Targeted-protein Degradation Therapeutics market is projected to grow from US$ 1266 million in 2024 to US$ 1821.4 million by 2030, at a Compound Annual Growth Rate (CAGR) of 6.3% during the forecast period.
The Protein Degradation Therapy market has gained momentum as a promising approach in drug development. This innovative strategy aims to target disease-causing proteins by facilitating their degradation within cells. Proteins that contribute to diseases like cancer and neurodegenerative disorders can be selectively broken down using small molecules known as proteolysis-targeting chimeras (PROTACs) or other protein degraders. This approach offers advantages over traditional inhibition methods, potentially leading to more effective treatments with reduced side effects. As researchers delve into protein-protein interactions and cellular mechanisms, the Protein Degradation Therapy market is expanding, presenting opportunities to address previously challenging diseases and advance precision medicine. Clinical progress and continued research in this field are expected to shape the future of therapeutic interventions.
Report Covers:
This report presents an overview of global market for Targeted-protein Degradation Therapeutics market size. Analyses of the global market trends, with historic market revenue data for 2019 - 2023, estimates for 2024, and projections of CAGR through 2030.
This report researches the key producers of Targeted-protein Degradation Therapeutics, also provides the revenue of main regions and countries. Highlights of the upcoming market potential for Targeted-protein Degradation Therapeutics, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Targeted-protein Degradation Therapeutics revenue, market share and industry ranking of main companies, data from 2019 to 2024. Identification of the major stakeholders in the global Targeted-protein Degradation Therapeutics market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2019 to 2030. Evaluation and forecast the market size for Targeted-protein Degradation Therapeutics revenue, projected growth trends, production technology, application and end-user industry.
Market Segmentation
By Company
Arvinas
Nurix Therapeutics
Kymera Therapeutics
C4 Therapeutics
Segment by Type
ARV-110
ARV-471
Other
Segment by Application
Cancer
Neuroscience
Other
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
China
Asia (excluding China)
Japan
South Korea
China Taiwan
Southeast Asia
India
Latin America, Middle East & Africa
Brazil
Mexico
Turkey
Israel
GCC Countries
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Revenue of Targeted-protein Degradation Therapeutics in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. This section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Targeted-protein Degradation Therapeutics companies’ competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: North America (US & Canada) by Type, by Application and by country, revenue for each segment.
Chapter 7: Europe by Type, by Application and by country, revenue for each segment.
Chapter 8: China by Type, and by Application, revenue for each segment.
Chapter 9: Asia (excluding China) by Type, by Application and by region, revenue for each segment.
Chapter 10: Middle East, Africa, and Latin America by Type, by Application and by country, revenue for each segment.
Chapter 11: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Targeted-protein Degradation Therapeutics revenue, gross margin, and recent development, etc.
Chapter 12: Analyst's Viewpoints/Conclusions
Market Analysis and Insights: Global Targeted-protein Degradation Therapeutics Market
The global Targeted-protein Degradation Therapeutics market is projected to grow from US$ 1266 million in 2024 to US$ 1821.4 million by 2030, at a Compound Annual Growth Rate (CAGR) of 6.3% during the forecast period.
The Protein Degradation Therapy market has gained momentum as a promising approach in drug development. This innovative strategy aims to target disease-causing proteins by facilitating their degradation within cells. Proteins that contribute to diseases like cancer and neurodegenerative disorders can be selectively broken down using small molecules known as proteolysis-targeting chimeras (PROTACs) or other protein degraders. This approach offers advantages over traditional inhibition methods, potentially leading to more effective treatments with reduced side effects. As researchers delve into protein-protein interactions and cellular mechanisms, the Protein Degradation Therapy market is expanding, presenting opportunities to address previously challenging diseases and advance precision medicine. Clinical progress and continued research in this field are expected to shape the future of therapeutic interventions.
Report Covers:
This report presents an overview of global market for Targeted-protein Degradation Therapeutics market size. Analyses of the global market trends, with historic market revenue data for 2019 - 2023, estimates for 2024, and projections of CAGR through 2030.
This report researches the key producers of Targeted-protein Degradation Therapeutics, also provides the revenue of main regions and countries. Highlights of the upcoming market potential for Targeted-protein Degradation Therapeutics, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Targeted-protein Degradation Therapeutics revenue, market share and industry ranking of main companies, data from 2019 to 2024. Identification of the major stakeholders in the global Targeted-protein Degradation Therapeutics market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2019 to 2030. Evaluation and forecast the market size for Targeted-protein Degradation Therapeutics revenue, projected growth trends, production technology, application and end-user industry.
Market Segmentation
By Company
Arvinas
Nurix Therapeutics
Kymera Therapeutics
C4 Therapeutics
Segment by Type
ARV-110
ARV-471
Other
Segment by Application
Cancer
Neuroscience
Other
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
China
Asia (excluding China)
Japan
South Korea
China Taiwan
Southeast Asia
India
Latin America, Middle East & Africa
Brazil
Mexico
Turkey
Israel
GCC Countries
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Revenue of Targeted-protein Degradation Therapeutics in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. This section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Targeted-protein Degradation Therapeutics companies’ competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: North America (US & Canada) by Type, by Application and by country, revenue for each segment.
Chapter 7: Europe by Type, by Application and by country, revenue for each segment.
Chapter 8: China by Type, and by Application, revenue for each segment.
Chapter 9: Asia (excluding China) by Type, by Application and by region, revenue for each segment.
Chapter 10: Middle East, Africa, and Latin America by Type, by Application and by country, revenue for each segment.
Chapter 11: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Targeted-protein Degradation Therapeutics revenue, gross margin, and recent development, etc.
Chapter 12: Analyst's Viewpoints/Conclusions
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Targeted-protein Degradation Therapeutics Market Size Growth Rate by Type, 2019 VS 2023 VS 2030
1.2.2 ARV-110
1.2.3 ARV-471
1.2.4 Other
1.3 Market by Application
1.3.1 Global Targeted-protein Degradation Therapeutics Market Size Growth Rate by Application, 2019 VS 2023 VS 2030
1.3.2 Cancer
1.3.3 Neuroscience
1.3.4 Other
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Targeted-protein Degradation Therapeutics Market Perspective (2019-2030)
2.2 Global Targeted-protein Degradation Therapeutics Growth Trends by Region
2.2.1 Targeted-protein Degradation Therapeutics Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Targeted-protein Degradation Therapeutics Historic Market Size by Region (2019-2024)
2.2.3 Targeted-protein Degradation Therapeutics Forecasted Market Size by Region (2025-2030)
2.3 Targeted-protein Degradation Therapeutics Market Dynamics
2.3.1 Targeted-protein Degradation Therapeutics Industry Trends
2.3.2 Targeted-protein Degradation Therapeutics Market Drivers
2.3.3 Targeted-protein Degradation Therapeutics Market Challenges
2.3.4 Targeted-protein Degradation Therapeutics Market Restraints
3 Competition Landscape by Key Players
3.1 Global Revenue Targeted-protein Degradation Therapeutics by Players
3.1.1 Global Targeted-protein Degradation Therapeutics Revenue by Players (2019-2024)
3.1.2 Global Targeted-protein Degradation Therapeutics Revenue Market Share by Players (2019-2024)
3.2 Global Targeted-protein Degradation Therapeutics Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players of Targeted-protein Degradation Therapeutics, Ranking by Revenue, 2022 VS 2023 VS 2024
3.4 Global Targeted-protein Degradation Therapeutics Market Concentration Ratio
3.4.1 Global Targeted-protein Degradation Therapeutics Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Targeted-protein Degradation Therapeutics Revenue in 2023
3.5 Global Key Players of Targeted-protein Degradation Therapeutics Head office and Area Served
3.6 Global Key Players of Targeted-protein Degradation Therapeutics, Product and Application
3.7 Global Key Players of Targeted-protein Degradation Therapeutics, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Targeted-protein Degradation Therapeutics Breakdown Data by Type
4.1 Global Targeted-protein Degradation Therapeutics Historic Market Size by Type (2019-2024)
4.2 Global Targeted-protein Degradation Therapeutics Forecasted Market Size by Type (2025-2030)
5 Targeted-protein Degradation Therapeutics Breakdown Data by Application
5.1 Global Targeted-protein Degradation Therapeutics Historic Market Size by Application (2019-2024)
5.2 Global Targeted-protein Degradation Therapeutics Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Targeted-protein Degradation Therapeutics Market Size (2019-2030)
6.2 North America Targeted-protein Degradation Therapeutics Market Size by Type
6.2.1 North America Targeted-protein Degradation Therapeutics Market Size by Type (2019-2024)
6.2.2 North America Targeted-protein Degradation Therapeutics Market Size by Type (2025-2030)
6.2.3 North America Targeted-protein Degradation Therapeutics Market Share by Type (2019-2030)
6.3 North America Targeted-protein Degradation Therapeutics Market Size by Application
6.3.1 North America Targeted-protein Degradation Therapeutics Market Size by Application (2019-2024)
6.3.2 North America Targeted-protein Degradation Therapeutics Market Size by Application (2025-2030)
6.3.3 North America Targeted-protein Degradation Therapeutics Market Share by Application (2019-2030)
6.4 North America Targeted-protein Degradation Therapeutics Market Size by Country
6.4.1 North America Targeted-protein Degradation Therapeutics Market Size by Country: 2019 VS 2023 VS 2030
6.4.2 North America Targeted-protein Degradation Therapeutics Market Size by Country (2019-2024)
6.4.3 North America Targeted-protein Degradation Therapeutics Market Size by Country (2025-2030)
6.4.4 United States
6.4.5 Canada
7 Europe
7.1 Europe Targeted-protein Degradation Therapeutics Market Size (2019-2030)
7.2 Europe Targeted-protein Degradation Therapeutics Market Size by Type
7.2.1 Europe Targeted-protein Degradation Therapeutics Market Size by Type (2019-2024)
7.2.2 Europe Targeted-protein Degradation Therapeutics Market Size by Type (2025-2030)
7.2.3 Europe Targeted-protein Degradation Therapeutics Market Share by Type (2019-2030)
7.3 Europe Targeted-protein Degradation Therapeutics Market Size by Application
7.3.1 Europe Targeted-protein Degradation Therapeutics Market Size by Application (2019-2024)
7.3.2 Europe Targeted-protein Degradation Therapeutics Market Size by Application (2025-2030)
7.3.3 Europe Targeted-protein Degradation Therapeutics Market Share by Application (2019-2030)
7.4 Europe Targeted-protein Degradation Therapeutics Market Size by Country
7.4.1 Europe Targeted-protein Degradation Therapeutics Market Size by Country: 2019 VS 2023 VS 2030
7.4.2 Europe Targeted-protein Degradation Therapeutics Market Size by Country (2019-2024)
7.4.3 Europe Targeted-protein Degradation Therapeutics Market Size by Country (2025-2030)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic Countries
8 China
8.1 China Targeted-protein Degradation Therapeutics Market Size (2019-2030)
8.2 China Targeted-protein Degradation Therapeutics Market Size by Type
8.2.1 China Targeted-protein Degradation Therapeutics Market Size by Type (2019-2024)
8.2.2 China Targeted-protein Degradation Therapeutics Market Size by Type (2025-2030)
8.2.3 China Targeted-protein Degradation Therapeutics Market Share by Type (2019-2030)
8.3 China Targeted-protein Degradation Therapeutics Market Size by Application
8.3.1 China Targeted-protein Degradation Therapeutics Market Size by Application (2019-2024)
8.3.2 China Targeted-protein Degradation Therapeutics Market Size by Application (2025-2030)
8.3.3 China Targeted-protein Degradation Therapeutics Market Share by Application (2019-2030)
9 Asia (excluding China)
9.1 Asia Targeted-protein Degradation Therapeutics Market Size (2019-2030)
9.2 Asia Targeted-protein Degradation Therapeutics Market Size by Type
9.2.1 Asia Targeted-protein Degradation Therapeutics Market Size by Type (2019-2024)
9.2.2 Asia Targeted-protein Degradation Therapeutics Market Size by Type (2025-2030)
9.2.3 Asia Targeted-protein Degradation Therapeutics Market Share by Type (2019-2030)
9.3 Asia Targeted-protein Degradation Therapeutics Market Size by Application
9.3.1 Asia Targeted-protein Degradation Therapeutics Market Size by Application (2019-2024)
9.3.2 Asia Targeted-protein Degradation Therapeutics Market Size by Application (2025-2030)
9.3.3 Asia Targeted-protein Degradation Therapeutics Market Share by Application (2019-2030)
9.4 Asia Targeted-protein Degradation Therapeutics Market Size by Region
9.4.1 Asia Targeted-protein Degradation Therapeutics Market Size by Region: 2019 VS 2023 VS 2030
9.4.2 Asia Targeted-protein Degradation Therapeutics Market Size by Region (2019-2024)
9.4.3 Asia Targeted-protein Degradation Therapeutics Market Size by Region (2025-2030)
9.4.4 Japan
9.4.5 South Korea
9.4.6 China Taiwan
9.4.7 Southeast Asia
9.4.8 India
9.4.9 Australia
10 Middle East, Africa, and Latin America
10.1 Middle East, Africa, and Latin America Targeted-protein Degradation Therapeutics Market Size (2019-2030)
10.2 Middle East, Africa, and Latin America Targeted-protein Degradation Therapeutics Market Size by Type
10.2.1 Middle East, Africa, and Latin America Targeted-protein Degradation Therapeutics Market Size by Type (2019-2024)
10.2.2 Middle East, Africa, and Latin America Targeted-protein Degradation Therapeutics Market Size by Type (2025-2030)
10.2.3 Middle East, Africa, and Latin America Targeted-protein Degradation Therapeutics Market Share by Type (2019-2030)
10.3 Middle East, Africa, and Latin America Targeted-protein Degradation Therapeutics Market Size by Application
10.3.1 Middle East, Africa, and Latin America Targeted-protein Degradation Therapeutics Market Size by Application (2019-2024)
10.3.2 Middle East, Africa, and Latin America Targeted-protein Degradation Therapeutics Market Size by Application (2025-2030)
10.3.3 Middle East, Africa, and Latin America Targeted-protein Degradation Therapeutics Market Share by Application (2019-2030)
10.4 Middle East, Africa, and Latin America Targeted-protein Degradation Therapeutics Market Size by Country
10.4.1 Middle East, Africa, and Latin America Targeted-protein Degradation Therapeutics Market Size by Country: 2019 VS 2023 VS 2030
10.4.2 Middle East, Africa, and Latin America Targeted-protein Degradation Therapeutics Market Size by Country (2019-2024)
10.4.3 Middle East, Africa, and Latin America Targeted-protein Degradation Therapeutics Market Size by Country (2025-2030)
10.4.4 Brazil
10.4.5 Mexico
10.4.6 Turkey
10.4.7 Saudi Arabia
10.4.8 Israel
10.4.9 GCC Countries
11 Key Players Profiles
11.1 Arvinas
11.1.1 Arvinas Company Details
11.1.2 Arvinas Business Overview
11.1.3 Arvinas Targeted-protein Degradation Therapeutics Introduction
11.1.4 Arvinas Revenue in Targeted-protein Degradation Therapeutics Business (2019-2024)
11.1.5 Arvinas Recent Developments
11.2 Nurix Therapeutics
11.2.1 Nurix Therapeutics Company Details
11.2.2 Nurix Therapeutics Business Overview
11.2.3 Nurix Therapeutics Targeted-protein Degradation Therapeutics Introduction
11.2.4 Nurix Therapeutics Revenue in Targeted-protein Degradation Therapeutics Business (2019-2024)
11.2.5 Nurix Therapeutics Recent Developments
11.3 Kymera Therapeutics
11.3.1 Kymera Therapeutics Company Details
11.3.2 Kymera Therapeutics Business Overview
11.3.3 Kymera Therapeutics Targeted-protein Degradation Therapeutics Introduction
11.3.4 Kymera Therapeutics Revenue in Targeted-protein Degradation Therapeutics Business (2019-2024)
11.3.5 Kymera Therapeutics Recent Developments
11.4 C4 Therapeutics
11.4.1 C4 Therapeutics Company Details
11.4.2 C4 Therapeutics Business Overview
11.4.3 C4 Therapeutics Targeted-protein Degradation Therapeutics Introduction
11.4.4 C4 Therapeutics Revenue in Targeted-protein Degradation Therapeutics Business (2019-2024)
11.4.5 C4 Therapeutics Recent Developments
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Targeted-protein Degradation Therapeutics Market Size Growth Rate by Type, 2019 VS 2023 VS 2030
1.2.2 ARV-110
1.2.3 ARV-471
1.2.4 Other
1.3 Market by Application
1.3.1 Global Targeted-protein Degradation Therapeutics Market Size Growth Rate by Application, 2019 VS 2023 VS 2030
1.3.2 Cancer
1.3.3 Neuroscience
1.3.4 Other
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Targeted-protein Degradation Therapeutics Market Perspective (2019-2030)
2.2 Global Targeted-protein Degradation Therapeutics Growth Trends by Region
2.2.1 Targeted-protein Degradation Therapeutics Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Targeted-protein Degradation Therapeutics Historic Market Size by Region (2019-2024)
2.2.3 Targeted-protein Degradation Therapeutics Forecasted Market Size by Region (2025-2030)
2.3 Targeted-protein Degradation Therapeutics Market Dynamics
2.3.1 Targeted-protein Degradation Therapeutics Industry Trends
2.3.2 Targeted-protein Degradation Therapeutics Market Drivers
2.3.3 Targeted-protein Degradation Therapeutics Market Challenges
2.3.4 Targeted-protein Degradation Therapeutics Market Restraints
3 Competition Landscape by Key Players
3.1 Global Revenue Targeted-protein Degradation Therapeutics by Players
3.1.1 Global Targeted-protein Degradation Therapeutics Revenue by Players (2019-2024)
3.1.2 Global Targeted-protein Degradation Therapeutics Revenue Market Share by Players (2019-2024)
3.2 Global Targeted-protein Degradation Therapeutics Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players of Targeted-protein Degradation Therapeutics, Ranking by Revenue, 2022 VS 2023 VS 2024
3.4 Global Targeted-protein Degradation Therapeutics Market Concentration Ratio
3.4.1 Global Targeted-protein Degradation Therapeutics Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Targeted-protein Degradation Therapeutics Revenue in 2023
3.5 Global Key Players of Targeted-protein Degradation Therapeutics Head office and Area Served
3.6 Global Key Players of Targeted-protein Degradation Therapeutics, Product and Application
3.7 Global Key Players of Targeted-protein Degradation Therapeutics, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Targeted-protein Degradation Therapeutics Breakdown Data by Type
4.1 Global Targeted-protein Degradation Therapeutics Historic Market Size by Type (2019-2024)
4.2 Global Targeted-protein Degradation Therapeutics Forecasted Market Size by Type (2025-2030)
5 Targeted-protein Degradation Therapeutics Breakdown Data by Application
5.1 Global Targeted-protein Degradation Therapeutics Historic Market Size by Application (2019-2024)
5.2 Global Targeted-protein Degradation Therapeutics Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Targeted-protein Degradation Therapeutics Market Size (2019-2030)
6.2 North America Targeted-protein Degradation Therapeutics Market Size by Type
6.2.1 North America Targeted-protein Degradation Therapeutics Market Size by Type (2019-2024)
6.2.2 North America Targeted-protein Degradation Therapeutics Market Size by Type (2025-2030)
6.2.3 North America Targeted-protein Degradation Therapeutics Market Share by Type (2019-2030)
6.3 North America Targeted-protein Degradation Therapeutics Market Size by Application
6.3.1 North America Targeted-protein Degradation Therapeutics Market Size by Application (2019-2024)
6.3.2 North America Targeted-protein Degradation Therapeutics Market Size by Application (2025-2030)
6.3.3 North America Targeted-protein Degradation Therapeutics Market Share by Application (2019-2030)
6.4 North America Targeted-protein Degradation Therapeutics Market Size by Country
6.4.1 North America Targeted-protein Degradation Therapeutics Market Size by Country: 2019 VS 2023 VS 2030
6.4.2 North America Targeted-protein Degradation Therapeutics Market Size by Country (2019-2024)
6.4.3 North America Targeted-protein Degradation Therapeutics Market Size by Country (2025-2030)
6.4.4 United States
6.4.5 Canada
7 Europe
7.1 Europe Targeted-protein Degradation Therapeutics Market Size (2019-2030)
7.2 Europe Targeted-protein Degradation Therapeutics Market Size by Type
7.2.1 Europe Targeted-protein Degradation Therapeutics Market Size by Type (2019-2024)
7.2.2 Europe Targeted-protein Degradation Therapeutics Market Size by Type (2025-2030)
7.2.3 Europe Targeted-protein Degradation Therapeutics Market Share by Type (2019-2030)
7.3 Europe Targeted-protein Degradation Therapeutics Market Size by Application
7.3.1 Europe Targeted-protein Degradation Therapeutics Market Size by Application (2019-2024)
7.3.2 Europe Targeted-protein Degradation Therapeutics Market Size by Application (2025-2030)
7.3.3 Europe Targeted-protein Degradation Therapeutics Market Share by Application (2019-2030)
7.4 Europe Targeted-protein Degradation Therapeutics Market Size by Country
7.4.1 Europe Targeted-protein Degradation Therapeutics Market Size by Country: 2019 VS 2023 VS 2030
7.4.2 Europe Targeted-protein Degradation Therapeutics Market Size by Country (2019-2024)
7.4.3 Europe Targeted-protein Degradation Therapeutics Market Size by Country (2025-2030)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic Countries
8 China
8.1 China Targeted-protein Degradation Therapeutics Market Size (2019-2030)
8.2 China Targeted-protein Degradation Therapeutics Market Size by Type
8.2.1 China Targeted-protein Degradation Therapeutics Market Size by Type (2019-2024)
8.2.2 China Targeted-protein Degradation Therapeutics Market Size by Type (2025-2030)
8.2.3 China Targeted-protein Degradation Therapeutics Market Share by Type (2019-2030)
8.3 China Targeted-protein Degradation Therapeutics Market Size by Application
8.3.1 China Targeted-protein Degradation Therapeutics Market Size by Application (2019-2024)
8.3.2 China Targeted-protein Degradation Therapeutics Market Size by Application (2025-2030)
8.3.3 China Targeted-protein Degradation Therapeutics Market Share by Application (2019-2030)
9 Asia (excluding China)
9.1 Asia Targeted-protein Degradation Therapeutics Market Size (2019-2030)
9.2 Asia Targeted-protein Degradation Therapeutics Market Size by Type
9.2.1 Asia Targeted-protein Degradation Therapeutics Market Size by Type (2019-2024)
9.2.2 Asia Targeted-protein Degradation Therapeutics Market Size by Type (2025-2030)
9.2.3 Asia Targeted-protein Degradation Therapeutics Market Share by Type (2019-2030)
9.3 Asia Targeted-protein Degradation Therapeutics Market Size by Application
9.3.1 Asia Targeted-protein Degradation Therapeutics Market Size by Application (2019-2024)
9.3.2 Asia Targeted-protein Degradation Therapeutics Market Size by Application (2025-2030)
9.3.3 Asia Targeted-protein Degradation Therapeutics Market Share by Application (2019-2030)
9.4 Asia Targeted-protein Degradation Therapeutics Market Size by Region
9.4.1 Asia Targeted-protein Degradation Therapeutics Market Size by Region: 2019 VS 2023 VS 2030
9.4.2 Asia Targeted-protein Degradation Therapeutics Market Size by Region (2019-2024)
9.4.3 Asia Targeted-protein Degradation Therapeutics Market Size by Region (2025-2030)
9.4.4 Japan
9.4.5 South Korea
9.4.6 China Taiwan
9.4.7 Southeast Asia
9.4.8 India
9.4.9 Australia
10 Middle East, Africa, and Latin America
10.1 Middle East, Africa, and Latin America Targeted-protein Degradation Therapeutics Market Size (2019-2030)
10.2 Middle East, Africa, and Latin America Targeted-protein Degradation Therapeutics Market Size by Type
10.2.1 Middle East, Africa, and Latin America Targeted-protein Degradation Therapeutics Market Size by Type (2019-2024)
10.2.2 Middle East, Africa, and Latin America Targeted-protein Degradation Therapeutics Market Size by Type (2025-2030)
10.2.3 Middle East, Africa, and Latin America Targeted-protein Degradation Therapeutics Market Share by Type (2019-2030)
10.3 Middle East, Africa, and Latin America Targeted-protein Degradation Therapeutics Market Size by Application
10.3.1 Middle East, Africa, and Latin America Targeted-protein Degradation Therapeutics Market Size by Application (2019-2024)
10.3.2 Middle East, Africa, and Latin America Targeted-protein Degradation Therapeutics Market Size by Application (2025-2030)
10.3.3 Middle East, Africa, and Latin America Targeted-protein Degradation Therapeutics Market Share by Application (2019-2030)
10.4 Middle East, Africa, and Latin America Targeted-protein Degradation Therapeutics Market Size by Country
10.4.1 Middle East, Africa, and Latin America Targeted-protein Degradation Therapeutics Market Size by Country: 2019 VS 2023 VS 2030
10.4.2 Middle East, Africa, and Latin America Targeted-protein Degradation Therapeutics Market Size by Country (2019-2024)
10.4.3 Middle East, Africa, and Latin America Targeted-protein Degradation Therapeutics Market Size by Country (2025-2030)
10.4.4 Brazil
10.4.5 Mexico
10.4.6 Turkey
10.4.7 Saudi Arabia
10.4.8 Israel
10.4.9 GCC Countries
11 Key Players Profiles
11.1 Arvinas
11.1.1 Arvinas Company Details
11.1.2 Arvinas Business Overview
11.1.3 Arvinas Targeted-protein Degradation Therapeutics Introduction
11.1.4 Arvinas Revenue in Targeted-protein Degradation Therapeutics Business (2019-2024)
11.1.5 Arvinas Recent Developments
11.2 Nurix Therapeutics
11.2.1 Nurix Therapeutics Company Details
11.2.2 Nurix Therapeutics Business Overview
11.2.3 Nurix Therapeutics Targeted-protein Degradation Therapeutics Introduction
11.2.4 Nurix Therapeutics Revenue in Targeted-protein Degradation Therapeutics Business (2019-2024)
11.2.5 Nurix Therapeutics Recent Developments
11.3 Kymera Therapeutics
11.3.1 Kymera Therapeutics Company Details
11.3.2 Kymera Therapeutics Business Overview
11.3.3 Kymera Therapeutics Targeted-protein Degradation Therapeutics Introduction
11.3.4 Kymera Therapeutics Revenue in Targeted-protein Degradation Therapeutics Business (2019-2024)
11.3.5 Kymera Therapeutics Recent Developments
11.4 C4 Therapeutics
11.4.1 C4 Therapeutics Company Details
11.4.2 C4 Therapeutics Business Overview
11.4.3 C4 Therapeutics Targeted-protein Degradation Therapeutics Introduction
11.4.4 C4 Therapeutics Revenue in Targeted-protein Degradation Therapeutics Business (2019-2024)
11.4.5 C4 Therapeutics Recent Developments
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
List of Tables
Table 1. Global Targeted-protein Degradation Therapeutics Market Size Growth Rate by Type (US$ Million), 2019 VS 2023 VS 2030
Table 2. Key Players of ARV-110
Table 3. Key Players of ARV-471
Table 4. Key Players of Other
Table 5. Global Targeted-protein Degradation Therapeutics Market Size Growth Rate by Application (US$ Million), 2019 VS 2023 VS 2030
Table 6. Global Targeted-protein Degradation Therapeutics Market Size Growth Rate (CAGR) by Region (US$ Million): 2019 VS 2023 VS 2030
Table 7. Global Targeted-protein Degradation Therapeutics Market Size by Region (2019-2024) & (US$ Million)
Table 8. Global Targeted-protein Degradation Therapeutics Market Share by Region (2019-2024)
Table 9. Global Targeted-protein Degradation Therapeutics Forecasted Market Size by Region (2025-2030) & (US$ Million)
Table 10. Global Targeted-protein Degradation Therapeutics Market Share by Region (2025-2030)
Table 11. Targeted-protein Degradation Therapeutics Market Trends
Table 12. Targeted-protein Degradation Therapeutics Market Drivers
Table 13. Targeted-protein Degradation Therapeutics Market Challenges
Table 14. Targeted-protein Degradation Therapeutics Market Restraints
Table 15. Global Targeted-protein Degradation Therapeutics Revenue by Players (2019-2024) & (US$ Million)
Table 16. Global Targeted-protein Degradation Therapeutics Revenue Share by Players (2019-2024)
Table 17. Global Top Targeted-protein Degradation Therapeutics by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Targeted-protein Degradation Therapeutics as of 2023)
Table 18. Global Targeted-protein Degradation Therapeutics Industry Ranking 2022 VS 2023 VS 2024
Table 19. Global 5 Largest Players Market Share by Targeted-protein Degradation Therapeutics Revenue (CR5 and HHI) & (2019-2024)
Table 20. Global Key Players of Targeted-protein Degradation Therapeutics, Headquarters and Area Served
Table 21. Global Key Players of Targeted-protein Degradation Therapeutics, Product and Application
Table 22. Global Key Players of Targeted-protein Degradation Therapeutics, Product and Application
Table 23. Mergers & Acquisitions, Expansion Plans
Table 24. Global Targeted-protein Degradation Therapeutics Market Size by Type (2019-2024) & (US$ Million)
Table 25. Global Targeted-protein Degradation Therapeutics Revenue Market Share by Type (2019-2024)
Table 26. Global Targeted-protein Degradation Therapeutics Forecasted Market Size by Type (2025-2030) & (US$ Million)
Table 27. Global Targeted-protein Degradation Therapeutics Revenue Market Share by Type (2025-2030)
Table 28. Global Targeted-protein Degradation Therapeutics Market Size by Application (2019-2024) & (US$ Million)
Table 29. Global Targeted-protein Degradation Therapeutics Revenue Share by Application (2019-2024)
Table 30. Global Targeted-protein Degradation Therapeutics Forecasted Market Size by Application (2025-2030) & (US$ Million)
Table 31. Global Targeted-protein Degradation Therapeutics Revenue Share by Application (2025-2030)
Table 32. North America Targeted-protein Degradation Therapeutics Market Size by Type (2019-2024) & (US$ Million)
Table 33. North America Targeted-protein Degradation Therapeutics Market Size by Type (2025-2030) & (US$ Million)
Table 34. North America Targeted-protein Degradation Therapeutics Market Size by Application (2019-2024) & (US$ Million)
Table 35. North America Targeted-protein Degradation Therapeutics Market Size by Application (2025-2030) & (US$ Million)
Table 36. North America Targeted-protein Degradation Therapeutics Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030
Table 37. North America Targeted-protein Degradation Therapeutics Market Size by Country (2019-2024) & (US$ Million)
Table 38. North America Targeted-protein Degradation Therapeutics Market Size by Country (2025-2030) & (US$ Million)
Table 39. Europe Targeted-protein Degradation Therapeutics Market Size by Type (2019-2024) & (US$ Million)
Table 40. Europe Targeted-protein Degradation Therapeutics Market Size by Type (2025-2030) & (US$ Million)
Table 41. Europe Targeted-protein Degradation Therapeutics Market Size by Application (2019-2024) & (US$ Million)
Table 42. Europe Targeted-protein Degradation Therapeutics Market Size by Application (2025-2030) & (US$ Million)
Table 43. Europe Targeted-protein Degradation Therapeutics Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030
Table 44. Europe Targeted-protein Degradation Therapeutics Market Size by Country (2019-2024) & (US$ Million)
Table 45. Europe Targeted-protein Degradation Therapeutics Market Size by Country (2025-2030) & (US$ Million)
Table 46. China Targeted-protein Degradation Therapeutics Market Size by Type (2019-2024) & (US$ Million)
Table 47. China Targeted-protein Degradation Therapeutics Market Size by Type (2025-2030) & (US$ Million)
Table 48. China Targeted-protein Degradation Therapeutics Market Size by Application (2019-2024) & (US$ Million)
Table 49. China Targeted-protein Degradation Therapeutics Market Size by Application (2025-2030) & (US$ Million)
Table 50. Asia Targeted-protein Degradation Therapeutics Market Size by Type (2019-2024) & (US$ Million)
Table 51. Asia Targeted-protein Degradation Therapeutics Market Size by Type (2025-2030) & (US$ Million)
Table 52. Asia Targeted-protein Degradation Therapeutics Market Size by Application (2019-2024) & (US$ Million)
Table 53. Asia Targeted-protein Degradation Therapeutics Market Size by Application (2025-2030) & (US$ Million)
Table 54. Asia Targeted-protein Degradation Therapeutics Growth Rate (CAGR) by Region (US$ Million): 2019 VS 2023 VS 2030
Table 55. Asia Targeted-protein Degradation Therapeutics Market Size by Region (2019-2024) & (US$ Million)
Table 56. Asia Targeted-protein Degradation Therapeutics Market Size by Region (2025-2030) & (US$ Million)
Table 57. Middle East, Africa, and Latin America Targeted-protein Degradation Therapeutics Market Size by Type (2019-2024) & (US$ Million)
Table 58. Middle East, Africa, and Latin America Targeted-protein Degradation Therapeutics Market Size by Type (2025-2030) & (US$ Million)
Table 59. Middle East, Africa, and Latin America Targeted-protein Degradation Therapeutics Market Size by Application (2019-2024) & (US$ Million)
Table 60. Middle East, Africa, and Latin America Targeted-protein Degradation Therapeutics Market Size by Application (2025-2030) & (US$ Million)
Table 61. Middle East, Africa, and Latin America Targeted-protein Degradation Therapeutics Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030
Table 62. Middle East, Africa, and Latin America Targeted-protein Degradation Therapeutics Market Size by Country (2019-2024) & (US$ Million)
Table 63. Middle East, Africa, and Latin America Targeted-protein Degradation Therapeutics Market Size by Country (2025-2030) & (US$ Million)
Table 64. Arvinas Company Details
Table 65. Arvinas Business Overview
Table 66. Arvinas Targeted-protein Degradation Therapeutics Product
Table 67. Arvinas Revenue in Targeted-protein Degradation Therapeutics Business (2019-2024) & (US$ Million)
Table 68. Arvinas Recent Developments
Table 69. Nurix Therapeutics Company Details
Table 70. Nurix Therapeutics Business Overview
Table 71. Nurix Therapeutics Targeted-protein Degradation Therapeutics Product
Table 72. Nurix Therapeutics Revenue in Targeted-protein Degradation Therapeutics Business (2019-2024) & (US$ Million)
Table 73. Nurix Therapeutics Recent Developments
Table 74. Kymera Therapeutics Company Details
Table 75. Kymera Therapeutics Business Overview
Table 76. Kymera Therapeutics Targeted-protein Degradation Therapeutics Product
Table 77. Kymera Therapeutics Revenue in Targeted-protein Degradation Therapeutics Business (2019-2024) & (US$ Million)
Table 78. Kymera Therapeutics Recent Developments
Table 79. C4 Therapeutics Company Details
Table 80. C4 Therapeutics Business Overview
Table 81. C4 Therapeutics Targeted-protein Degradation Therapeutics Product
Table 82. C4 Therapeutics Revenue in Targeted-protein Degradation Therapeutics Business (2019-2024) & (US$ Million)
Table 83. C4 Therapeutics Recent Developments
Table 84. Research Programs/Design for This Report
Table 85. Key Data Information from Secondary Sources
Table 86. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Targeted-protein Degradation Therapeutics Market Size Growth Rate by Type, 2019 VS 2023 VS 2030 (US$ Million)
Figure 2. Global Targeted-protein Degradation Therapeutics Market Share by Type: 2023 VS 2030
Figure 3. ARV-110 Features
Figure 4. ARV-471 Features
Figure 5. Other Features
Figure 6. Global Targeted-protein Degradation Therapeutics Market Size Growth Rate by Application, 2019 VS 2023 VS 2030 (US$ Million)
Figure 7. Global Targeted-protein Degradation Therapeutics Market Share by Application: 2023 VS 2030
Figure 8. Cancer Case Studies
Figure 9. Neuroscience Case Studies
Figure 10. Other Case Studies
Figure 11. Targeted-protein Degradation Therapeutics Report Years Considered
Figure 12. Global Targeted-protein Degradation Therapeutics Market Size (US$ Million), Year-over-Year: 2019-2030
Figure 13. Global Targeted-protein Degradation Therapeutics Market Size, (US$ Million), 2019 VS 2023 VS 2030
Figure 14. Global Targeted-protein Degradation Therapeutics Market Share by Region: 2023 VS 2030
Figure 15. Global Targeted-protein Degradation Therapeutics Market Share by Players in 2023
Figure 16. Global Top Targeted-protein Degradation Therapeutics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Targeted-protein Degradation Therapeutics as of 2023)
Figure 17. The Top 10 and 5 Players Market Share by Targeted-protein Degradation Therapeutics Revenue in 2023
Figure 18. North America Targeted-protein Degradation Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 19. North America Targeted-protein Degradation Therapeutics Market Share by Type (2019-2030)
Figure 20. North America Targeted-protein Degradation Therapeutics Market Share by Application (2019-2030)
Figure 21. North America Targeted-protein Degradation Therapeutics Market Share by Country (2019-2030)
Figure 22. United States Targeted-protein Degradation Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 23. Canada Targeted-protein Degradation Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 24. Europe Targeted-protein Degradation Therapeutics Market Size YoY (2019-2030) & (US$ Million)
Figure 25. Europe Targeted-protein Degradation Therapeutics Market Share by Type (2019-2030)
Figure 26. Europe Targeted-protein Degradation Therapeutics Market Share by Application (2019-2030)
Figure 27. Europe Targeted-protein Degradation Therapeutics Market Share by Country (2019-2030)
Figure 28. Germany Targeted-protein Degradation Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 29. France Targeted-protein Degradation Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 30. U.K. Targeted-protein Degradation Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 31. Italy Targeted-protein Degradation Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 32. Russia Targeted-protein Degradation Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 33. Nordic Countries Targeted-protein Degradation Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 34. China Targeted-protein Degradation Therapeutics Market Size YoY (2019-2030) & (US$ Million)
Figure 35. China Targeted-protein Degradation Therapeutics Market Share by Type (2019-2030)
Figure 36. China Targeted-protein Degradation Therapeutics Market Share by Application (2019-2030)
Figure 37. Asia Targeted-protein Degradation Therapeutics Market Size YoY (2019-2030) & (US$ Million)
Figure 38. Asia Targeted-protein Degradation Therapeutics Market Share by Type (2019-2030)
Figure 39. Asia Targeted-protein Degradation Therapeutics Market Share by Application (2019-2030)
Figure 40. Asia Targeted-protein Degradation Therapeutics Market Share by Region (2019-2030)
Figure 41. Japan Targeted-protein Degradation Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 42. South Korea Targeted-protein Degradation Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 43. China Taiwan Targeted-protein Degradation Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 44. Southeast Asia Targeted-protein Degradation Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 45. India Targeted-protein Degradation Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 46. Australia Targeted-protein Degradation Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 47. Middle East, Africa, and Latin America Targeted-protein Degradation Therapeutics Market Size YoY (2019-2030) & (US$ Million)
Figure 48. Middle East, Africa, and Latin America Targeted-protein Degradation Therapeutics Market Share by Type (2019-2030)
Figure 49. Middle East, Africa, and Latin America Targeted-protein Degradation Therapeutics Market Share by Application (2019-2030)
Figure 50. Middle East, Africa, and Latin America Targeted-protein Degradation Therapeutics Market Share by Country (2019-2030)
Figure 51. Brazil Targeted-protein Degradation Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 52. Mexico Targeted-protein Degradation Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 53. Turkey Targeted-protein Degradation Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 54. Saudi Arabia Targeted-protein Degradation Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 55. Israel Targeted-protein Degradation Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 56. GCC Countries Targeted-protein Degradation Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 57. Arvinas Revenue Growth Rate in Targeted-protein Degradation Therapeutics Business (2019-2024)
Figure 58. Nurix Therapeutics Revenue Growth Rate in Targeted-protein Degradation Therapeutics Business (2019-2024)
Figure 59. Kymera Therapeutics Revenue Growth Rate in Targeted-protein Degradation Therapeutics Business (2019-2024)
Figure 60. C4 Therapeutics Revenue Growth Rate in Targeted-protein Degradation Therapeutics Business (2019-2024)
Figure 61. Bottom-up and Top-down Approaches for This Report
Figure 62. Data Triangulation
Figure 63. Key Executives Interviewed
Table 1. Global Targeted-protein Degradation Therapeutics Market Size Growth Rate by Type (US$ Million), 2019 VS 2023 VS 2030
Table 2. Key Players of ARV-110
Table 3. Key Players of ARV-471
Table 4. Key Players of Other
Table 5. Global Targeted-protein Degradation Therapeutics Market Size Growth Rate by Application (US$ Million), 2019 VS 2023 VS 2030
Table 6. Global Targeted-protein Degradation Therapeutics Market Size Growth Rate (CAGR) by Region (US$ Million): 2019 VS 2023 VS 2030
Table 7. Global Targeted-protein Degradation Therapeutics Market Size by Region (2019-2024) & (US$ Million)
Table 8. Global Targeted-protein Degradation Therapeutics Market Share by Region (2019-2024)
Table 9. Global Targeted-protein Degradation Therapeutics Forecasted Market Size by Region (2025-2030) & (US$ Million)
Table 10. Global Targeted-protein Degradation Therapeutics Market Share by Region (2025-2030)
Table 11. Targeted-protein Degradation Therapeutics Market Trends
Table 12. Targeted-protein Degradation Therapeutics Market Drivers
Table 13. Targeted-protein Degradation Therapeutics Market Challenges
Table 14. Targeted-protein Degradation Therapeutics Market Restraints
Table 15. Global Targeted-protein Degradation Therapeutics Revenue by Players (2019-2024) & (US$ Million)
Table 16. Global Targeted-protein Degradation Therapeutics Revenue Share by Players (2019-2024)
Table 17. Global Top Targeted-protein Degradation Therapeutics by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Targeted-protein Degradation Therapeutics as of 2023)
Table 18. Global Targeted-protein Degradation Therapeutics Industry Ranking 2022 VS 2023 VS 2024
Table 19. Global 5 Largest Players Market Share by Targeted-protein Degradation Therapeutics Revenue (CR5 and HHI) & (2019-2024)
Table 20. Global Key Players of Targeted-protein Degradation Therapeutics, Headquarters and Area Served
Table 21. Global Key Players of Targeted-protein Degradation Therapeutics, Product and Application
Table 22. Global Key Players of Targeted-protein Degradation Therapeutics, Product and Application
Table 23. Mergers & Acquisitions, Expansion Plans
Table 24. Global Targeted-protein Degradation Therapeutics Market Size by Type (2019-2024) & (US$ Million)
Table 25. Global Targeted-protein Degradation Therapeutics Revenue Market Share by Type (2019-2024)
Table 26. Global Targeted-protein Degradation Therapeutics Forecasted Market Size by Type (2025-2030) & (US$ Million)
Table 27. Global Targeted-protein Degradation Therapeutics Revenue Market Share by Type (2025-2030)
Table 28. Global Targeted-protein Degradation Therapeutics Market Size by Application (2019-2024) & (US$ Million)
Table 29. Global Targeted-protein Degradation Therapeutics Revenue Share by Application (2019-2024)
Table 30. Global Targeted-protein Degradation Therapeutics Forecasted Market Size by Application (2025-2030) & (US$ Million)
Table 31. Global Targeted-protein Degradation Therapeutics Revenue Share by Application (2025-2030)
Table 32. North America Targeted-protein Degradation Therapeutics Market Size by Type (2019-2024) & (US$ Million)
Table 33. North America Targeted-protein Degradation Therapeutics Market Size by Type (2025-2030) & (US$ Million)
Table 34. North America Targeted-protein Degradation Therapeutics Market Size by Application (2019-2024) & (US$ Million)
Table 35. North America Targeted-protein Degradation Therapeutics Market Size by Application (2025-2030) & (US$ Million)
Table 36. North America Targeted-protein Degradation Therapeutics Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030
Table 37. North America Targeted-protein Degradation Therapeutics Market Size by Country (2019-2024) & (US$ Million)
Table 38. North America Targeted-protein Degradation Therapeutics Market Size by Country (2025-2030) & (US$ Million)
Table 39. Europe Targeted-protein Degradation Therapeutics Market Size by Type (2019-2024) & (US$ Million)
Table 40. Europe Targeted-protein Degradation Therapeutics Market Size by Type (2025-2030) & (US$ Million)
Table 41. Europe Targeted-protein Degradation Therapeutics Market Size by Application (2019-2024) & (US$ Million)
Table 42. Europe Targeted-protein Degradation Therapeutics Market Size by Application (2025-2030) & (US$ Million)
Table 43. Europe Targeted-protein Degradation Therapeutics Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030
Table 44. Europe Targeted-protein Degradation Therapeutics Market Size by Country (2019-2024) & (US$ Million)
Table 45. Europe Targeted-protein Degradation Therapeutics Market Size by Country (2025-2030) & (US$ Million)
Table 46. China Targeted-protein Degradation Therapeutics Market Size by Type (2019-2024) & (US$ Million)
Table 47. China Targeted-protein Degradation Therapeutics Market Size by Type (2025-2030) & (US$ Million)
Table 48. China Targeted-protein Degradation Therapeutics Market Size by Application (2019-2024) & (US$ Million)
Table 49. China Targeted-protein Degradation Therapeutics Market Size by Application (2025-2030) & (US$ Million)
Table 50. Asia Targeted-protein Degradation Therapeutics Market Size by Type (2019-2024) & (US$ Million)
Table 51. Asia Targeted-protein Degradation Therapeutics Market Size by Type (2025-2030) & (US$ Million)
Table 52. Asia Targeted-protein Degradation Therapeutics Market Size by Application (2019-2024) & (US$ Million)
Table 53. Asia Targeted-protein Degradation Therapeutics Market Size by Application (2025-2030) & (US$ Million)
Table 54. Asia Targeted-protein Degradation Therapeutics Growth Rate (CAGR) by Region (US$ Million): 2019 VS 2023 VS 2030
Table 55. Asia Targeted-protein Degradation Therapeutics Market Size by Region (2019-2024) & (US$ Million)
Table 56. Asia Targeted-protein Degradation Therapeutics Market Size by Region (2025-2030) & (US$ Million)
Table 57. Middle East, Africa, and Latin America Targeted-protein Degradation Therapeutics Market Size by Type (2019-2024) & (US$ Million)
Table 58. Middle East, Africa, and Latin America Targeted-protein Degradation Therapeutics Market Size by Type (2025-2030) & (US$ Million)
Table 59. Middle East, Africa, and Latin America Targeted-protein Degradation Therapeutics Market Size by Application (2019-2024) & (US$ Million)
Table 60. Middle East, Africa, and Latin America Targeted-protein Degradation Therapeutics Market Size by Application (2025-2030) & (US$ Million)
Table 61. Middle East, Africa, and Latin America Targeted-protein Degradation Therapeutics Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030
Table 62. Middle East, Africa, and Latin America Targeted-protein Degradation Therapeutics Market Size by Country (2019-2024) & (US$ Million)
Table 63. Middle East, Africa, and Latin America Targeted-protein Degradation Therapeutics Market Size by Country (2025-2030) & (US$ Million)
Table 64. Arvinas Company Details
Table 65. Arvinas Business Overview
Table 66. Arvinas Targeted-protein Degradation Therapeutics Product
Table 67. Arvinas Revenue in Targeted-protein Degradation Therapeutics Business (2019-2024) & (US$ Million)
Table 68. Arvinas Recent Developments
Table 69. Nurix Therapeutics Company Details
Table 70. Nurix Therapeutics Business Overview
Table 71. Nurix Therapeutics Targeted-protein Degradation Therapeutics Product
Table 72. Nurix Therapeutics Revenue in Targeted-protein Degradation Therapeutics Business (2019-2024) & (US$ Million)
Table 73. Nurix Therapeutics Recent Developments
Table 74. Kymera Therapeutics Company Details
Table 75. Kymera Therapeutics Business Overview
Table 76. Kymera Therapeutics Targeted-protein Degradation Therapeutics Product
Table 77. Kymera Therapeutics Revenue in Targeted-protein Degradation Therapeutics Business (2019-2024) & (US$ Million)
Table 78. Kymera Therapeutics Recent Developments
Table 79. C4 Therapeutics Company Details
Table 80. C4 Therapeutics Business Overview
Table 81. C4 Therapeutics Targeted-protein Degradation Therapeutics Product
Table 82. C4 Therapeutics Revenue in Targeted-protein Degradation Therapeutics Business (2019-2024) & (US$ Million)
Table 83. C4 Therapeutics Recent Developments
Table 84. Research Programs/Design for This Report
Table 85. Key Data Information from Secondary Sources
Table 86. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Targeted-protein Degradation Therapeutics Market Size Growth Rate by Type, 2019 VS 2023 VS 2030 (US$ Million)
Figure 2. Global Targeted-protein Degradation Therapeutics Market Share by Type: 2023 VS 2030
Figure 3. ARV-110 Features
Figure 4. ARV-471 Features
Figure 5. Other Features
Figure 6. Global Targeted-protein Degradation Therapeutics Market Size Growth Rate by Application, 2019 VS 2023 VS 2030 (US$ Million)
Figure 7. Global Targeted-protein Degradation Therapeutics Market Share by Application: 2023 VS 2030
Figure 8. Cancer Case Studies
Figure 9. Neuroscience Case Studies
Figure 10. Other Case Studies
Figure 11. Targeted-protein Degradation Therapeutics Report Years Considered
Figure 12. Global Targeted-protein Degradation Therapeutics Market Size (US$ Million), Year-over-Year: 2019-2030
Figure 13. Global Targeted-protein Degradation Therapeutics Market Size, (US$ Million), 2019 VS 2023 VS 2030
Figure 14. Global Targeted-protein Degradation Therapeutics Market Share by Region: 2023 VS 2030
Figure 15. Global Targeted-protein Degradation Therapeutics Market Share by Players in 2023
Figure 16. Global Top Targeted-protein Degradation Therapeutics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Targeted-protein Degradation Therapeutics as of 2023)
Figure 17. The Top 10 and 5 Players Market Share by Targeted-protein Degradation Therapeutics Revenue in 2023
Figure 18. North America Targeted-protein Degradation Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 19. North America Targeted-protein Degradation Therapeutics Market Share by Type (2019-2030)
Figure 20. North America Targeted-protein Degradation Therapeutics Market Share by Application (2019-2030)
Figure 21. North America Targeted-protein Degradation Therapeutics Market Share by Country (2019-2030)
Figure 22. United States Targeted-protein Degradation Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 23. Canada Targeted-protein Degradation Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 24. Europe Targeted-protein Degradation Therapeutics Market Size YoY (2019-2030) & (US$ Million)
Figure 25. Europe Targeted-protein Degradation Therapeutics Market Share by Type (2019-2030)
Figure 26. Europe Targeted-protein Degradation Therapeutics Market Share by Application (2019-2030)
Figure 27. Europe Targeted-protein Degradation Therapeutics Market Share by Country (2019-2030)
Figure 28. Germany Targeted-protein Degradation Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 29. France Targeted-protein Degradation Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 30. U.K. Targeted-protein Degradation Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 31. Italy Targeted-protein Degradation Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 32. Russia Targeted-protein Degradation Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 33. Nordic Countries Targeted-protein Degradation Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 34. China Targeted-protein Degradation Therapeutics Market Size YoY (2019-2030) & (US$ Million)
Figure 35. China Targeted-protein Degradation Therapeutics Market Share by Type (2019-2030)
Figure 36. China Targeted-protein Degradation Therapeutics Market Share by Application (2019-2030)
Figure 37. Asia Targeted-protein Degradation Therapeutics Market Size YoY (2019-2030) & (US$ Million)
Figure 38. Asia Targeted-protein Degradation Therapeutics Market Share by Type (2019-2030)
Figure 39. Asia Targeted-protein Degradation Therapeutics Market Share by Application (2019-2030)
Figure 40. Asia Targeted-protein Degradation Therapeutics Market Share by Region (2019-2030)
Figure 41. Japan Targeted-protein Degradation Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 42. South Korea Targeted-protein Degradation Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 43. China Taiwan Targeted-protein Degradation Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 44. Southeast Asia Targeted-protein Degradation Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 45. India Targeted-protein Degradation Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 46. Australia Targeted-protein Degradation Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 47. Middle East, Africa, and Latin America Targeted-protein Degradation Therapeutics Market Size YoY (2019-2030) & (US$ Million)
Figure 48. Middle East, Africa, and Latin America Targeted-protein Degradation Therapeutics Market Share by Type (2019-2030)
Figure 49. Middle East, Africa, and Latin America Targeted-protein Degradation Therapeutics Market Share by Application (2019-2030)
Figure 50. Middle East, Africa, and Latin America Targeted-protein Degradation Therapeutics Market Share by Country (2019-2030)
Figure 51. Brazil Targeted-protein Degradation Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 52. Mexico Targeted-protein Degradation Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 53. Turkey Targeted-protein Degradation Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 54. Saudi Arabia Targeted-protein Degradation Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 55. Israel Targeted-protein Degradation Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 56. GCC Countries Targeted-protein Degradation Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 57. Arvinas Revenue Growth Rate in Targeted-protein Degradation Therapeutics Business (2019-2024)
Figure 58. Nurix Therapeutics Revenue Growth Rate in Targeted-protein Degradation Therapeutics Business (2019-2024)
Figure 59. Kymera Therapeutics Revenue Growth Rate in Targeted-protein Degradation Therapeutics Business (2019-2024)
Figure 60. C4 Therapeutics Revenue Growth Rate in Targeted-protein Degradation Therapeutics Business (2019-2024)
Figure 61. Bottom-up and Top-down Approaches for This Report
Figure 62. Data Triangulation
Figure 63. Key Executives Interviewed
Our team would be happy to assist you with your queries.
About us
Accurate data, The latest market trends, And deeper research directions.
Our sole purpose is to provide a basis for leaders in all walks of life to make more appropriate decisions, to help companies solve existing problems and achieve business goals
Latest reports
Global Circuit Simulator Market Research Report 2025
Mar 11, 25
Global Schematic Editor Market Research Report 2025
Mar 11, 25
Global Milk Green Tea Market Research Report 2025
Mar 11, 25
Useful links
Our Contacts
Room 2306, T6 Fuxing World Financial Center, Kaifu District, Changsha, Hunan, China
(+86) 159 1069 5232